Market Analysis Report Oligonucleotide Testing Market

Your Catalyst to a Lucrative Business Oligonucleotide Testing Market Share, Size,Growth, Opportunities, Research and Forecasts to 2024 | Hexa Research “ The global oligonucleotide testing market to reach USD 1,746.52 million by 2024.” 20 November 2018 The global oligonucleotide testing market to reach USD 1,746.52 million by 2024, owing to the increasing research and development activities in the field of oligonucleotide. For instance, nowadays, multifunctional oligonucleotide based aptamer molecules are widely studied biomedical class among scienti sts across the globe. Due to its unique chemistry and potential advantages compared to currently available drugs (i.e. antibodies), aptamer became one of the most budding market for the future period. With the rising concept of oligonucleotide as diagnostic, research and therapeutic agent, it is noticed that companies investigating the potential of oligonucleotide is going up. Number of small companies or start -ups entering the market is continuously increasing due to its potential advantages. Over the pas t few years, there has been explosive growth in number of research article published in the area of oligonucleotide and its products. According to the open access journal Multidisciplinary Digital Publishing Institute (MDPI AG), in 1995, there were not more than 200 research articles on aptamers. Compare to this, now it is around 1800 research literatures published by scientist on aptamer assays or therapeutics. This number indicates that companies focusing on the oligonucleotide drugs is rising every year. This fact would in turn cause a surge in demand for oligonucleotide testing services, augmenting growth. However, strict regulatory framework is anticipated to hamper the market expansion to some extent. Types segment is categorized into Instrument, Software, and Services. Among which, instrument segment captured the largest share of the total market. Introduction of technological advanced chromatographic Follow Us: